Department of Radiation Medicine & Applied Science - Open Access Policy Deposits

eScholarship stats: History by Item for June through September, 2026

Item	Title	Total requests	2026-09	2026-08	2026-07	2026-06
5tx5x76f	Immunotherapy and radiation therapy sequencing: State of the data on timing, efficacy, and safety	810	154	241	204	211
8v30f9qz	Breast Cancer Risk Genes — Association Analysis in More than 113,000 Women	530	103	128	91	208
2sm5p2fb	Red Flag Signs and Symptoms for Patients With Early-Onset Colorectal Cancer	460	181	186	42	51
86c52204	AAPM task group report 302: Surface‐guided radiotherapy	408	92	205	54	57
2rr82304	Non-invasive bladder function measures in healthy, asymptomatic female children and adolescents: A systematic review and meta-analysis	335	127	144	42	22
64q353j6	Genetic and Regulatory Mechanisms of Comorbidity of Anxiety, Depression and ADHD: A GWAS Meta-Meta-Analysis Through the Lens of a System Biological and Pharmacogenomic Perspective in 18.5 M Subjects	327	107	92	41	87
1r05b09c	Safety and Efficacy of a Five-Fraction Stereotactic Body Radiotherapy Schedule for Centrally Located Non-Small-Cell Lung Cancer: NRG Oncology/RTOG 0813 Trial.	322	96	92	30	104
8zp2p19k	Design and Validation of Miniaturized Repetitive Transcranial Magnetic Stimulation (rTMS) Head Coils	316	63	82	45	126
79w4r3qf	The tumor-sentinel lymph node immuno-migratome reveals CCR7⁺ dendritic cells drive response to sequenced immunoradiotherapy	307	75	139	51	42
7861k3pc	Emerging role of immunogenic cell death in cancer immunotherapy	303	45	85	73	100
8xt673k7	Global challenges of radiotherapy for the treatment of locally advanced cervical cancer	281	15	27	114	125
00j856g9	Disruption of the HER3-PI3K-mTOR oncogenic signaling axis and PD-1 blockade as a multimodal precision immunotherapy in head and neck cancer	260	35	52	69	104
8mn2q2cr	Additional SNPs improve risk stratification of a polygenic hazard score for prostate cancer	252	53	132	42	25
7bd8z06q	The renal clear cell carcinoma immune landscape	242	53	112	33	44
8m76099g	Proton Therapy for Breast Cancer: A Consensus Statement From the Particle Therapy Cooperative Group Breast Cancer Subcommittee	237	59	95	40	43
5n37184s	The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)	227	73	67	31	56
09z3n20n	Reproductive risk factors and breast cancer subtypes: a review of the literature	223	20	60	70	73
36q7h95d	Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses	221	50	68	51	52
5df972fc	Clinical Guidelines for the Emergency Department Evaluation of Subarachnoid Hemorrhage	221	72	64	35	50
501663s9	Review of the medical and legal literature on restraint chairs	219	42	67	33	77
2mg8p2dv	Head and neck cancers, Version 2.2014. Clinical practice guidelines in oncology.	217	56	83	49	29
5fn033tg	Dopamine Dysregulation in Reward and Autism Spectrum Disorder.	210	43	51	46	70
34974766	Radiation-Induced Volume Changes in the Parotid and Submandibular Glands, Intra-Gland Dose Distribution, and Quality of Life Scores Over a Long Follow-Up Period	202	86	33	25	58
6j76s343	Genetic Stratification of Age‐Dependent Parkinson's Disease Risk by Polygenic Hazard Score	202	11	135	39	17
73k820f8	Performance of African-ancestry-specific polygenic hazard score varies according to local ancestry in 8q24	201	17	108	22	54
6fh9b1p2	African‐specific improvement of a polygenic hazard score for age at diagnosis of prostate cancer	200	14	130	33	23
1175j88p	Risk of Incident and Fatal Colorectal Cancer After Young-Onset Adenoma Diagnosis: A National Cohort Study	199	67	46	40	46
9v72021h	[18F]Fluoro-2-deoxy-2-d-glucose versus 3′-deoxy-3′-[18F]fluorothymidine for defining hematopoietically active pelvic bone marrow in gynecologic patients	198	20	132	19	27
66j3g23q	Mendelian randomisation study of smoking exposure in relation to breast cancer risk	196	45	79	33	39
7009d51p	Cancer-related Emergency Department Visits: Comparing Characteristics and Outcomes	196	41	52	36	67
4xs9q63g	Targeting prostate tumor low–molecular weight tyrosine phosphatase for oxidation-sensitizing therapy	193	55	47	33	58
6gh7s7sr	Development of Conceptual Models to Guide Public Health Research, Practice, and Policy: Synthesizing Traditional and Contemporary Paradigms	193	74	33	22	64
6gh2t3c7	Protocol to study the immune profile of syngeneic mouse tumor models	189	66	47	17	59
0v47k6m8	NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018.	184	23	62	48	51
17f6g4gh	Opioid tapering in older cancer survivors does not increase psychiatric or drug hospitalization rates	182	33	63	48	38
2jx5t1xh	Treatment Landscape of Renal Cell Carcinoma	182	29	40	33	80
7806p41z	Phase I Trial of Intravenous Oncolytic Vaccinia Virus (GL-ONC1) with Cisplatin and Radiotherapy in Patients with Locoregionally Advanced Head and Neck Carcinoma	182	42	46	47	47
0p1312b0	Characteristics and Outcomes of T1a Renal Cell Carcinoma Presenting with Metastasis	179	52	45	44	38
9m38g641	Abnormalities in hippocampal volume of glioma patients prior to radiotherapy	177	7	120	27	23
6rq0c7z3	The effect of sample size on polygenic hazard models for prostate cancer	175	16	109	34	16
9x51g6ff	The Role of Optical Surface Imaging Systems in Radiation Therapy	174	40	62	22	50
3rh5061n	Human papillomavirus E5 suppresses immunity via inhibition of the immunoproteasome and STING pathway	173	42	50	18	63
74s5j6qc	Review article: Lynch Syndrome—a mechanistic and clinical management update	170	57	48	27	38
2p59p3db	Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants	166	29	46	19	72
54r1d8c3	Precision Chemoradiotherapy for HER2 Tumors Using Antibody Conjugates of an Auristatin Derivative with Reduced Cell Permeability	166	29	50	31	56
50d1541v	Fast and efficient QTL mapper for thousands of molecular phenotypes	164	41	53	22	48
0g74s18q	Personalized repetitive transcranial magnetic stimulation (prtms®) for post-traumatic stress disorder (ptsd) in military combat veterans	163	31	45	42	45
8fj8q5j7	Risk stratification of individuals with low-risk colorectal adenomas using clinical characteristics: a pooled analysis	161	51	71	16	23
0kp9k26f	Analysis of more than 400,000 women provides case-control evidence for BRCA1 and BRCA2 variant classification	160	71	45	16	28
18w5121s	Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes	159	43	47	22	47

Top

Note: Due to the evolving nature of web traffic, the data presented here should be considered approximate and subject to revision. Learn more.